Clever Way, Lu Yang report 9.96% Universe stake
Universe Pharmaceuticals INC (UPC) received a Schedule 13G reporting passive beneficial ownership of its Class A ordinary shares by Clever Way Global Limited and Lu Yang.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Universe Pharmaceuticals INC (UPC) received a Schedule 13G reporting passive beneficial ownership of its Class A ordinary shares by Clever Way Global Limited and Lu Yang. The filing states that Clever Way Global Limited beneficially owns 498,922 Class A ordinary shares, all of which are also attributed to Lu Yang through ownership and control of Clever Way Global Limited. This position represents 9.96% of the Class A ordinary shares, based on 5,008,313 shares outstanding as of July 27, 2026. Voting and dispositive power over these shares is reported as shared, with no sole voting or dispositive power for either reporting person.
Key Figures
Key Terms
Schedule 13G regulatory
beneficially owned financial
percent of class financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of Universe Pharmaceuticals INC (UPC) does Clever Way Global Limited own?
What is the relationship between Clever Way Global Limited and Lu Yang in the UPC Schedule 13G?
AI-generated analysis. How Rhea-AI works. Not financial advice.